Project Details
| Short title | Assessing the Therapeutic Efficacy of an 11Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in Idiopathic Intracranial Hypertension (IIH) |
|---|---|
| Status | Finished |
| Effective start/end date | 12/08/13 → 11/08/17 |
Funding
- Medical Research Council
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
-
A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertension
Mitchell, J. L., Lyons, H. S., Walker, J. K., Yiangou, A., Thaller, M., Grech, O., Alimajstorovic, Z., Tsermoulas, G., Brock, K., Mollan, S. P. & Sinclair, A. J., Feb 2025, In: Headache. 65, 2, p. 258-268 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile47 Downloads (Pure) -
Non-invasive assessment of intracranial compliance in idiopathic intracranial hypertension: an MRI-ICP study
Sassani, M., Mitchell, J. L., Yiangou, A., Davies, N., Sawlani, V., Mollan, S. P., Wagshul, M. E. & Sinclair, A. J., 24 Jan 2025, (E-pub ahead of print) In: Eye (London, England).Research output: Contribution to journal › Article › peer-review
Open AccessFile39 Downloads (Pure) -
Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension
Grech, O., Mitchell, J. L., Lyons, H. S., Yiangou, A., Thaller, M., Tsermoulas, G., Brock, K., Mollan, S. P. & Sinclair, A. J., May 2024, In: Eye. 38, 7, p. 1374-1379 6 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile57 Downloads (Pure)